FinTechFunding

Medibio: Launches $1.4m placement, CEO resigns

Medibio Launches $1.4m placement, CEO resigns

  • Medibio (MEB) receives firm commitments to raise $1.4 million via placement to fund its US Food and Drug Administration (FDA) application and for working capital
  • The company will issue approximately 923.6 million shares at 0.15 cents over two tranches, with the offer of one free-attaching option for every one new share issued
  • Additionally, Claude Solitario has resigned as CEO and Managing Director to pursue other business interests, effective today
  • The search for a new CEO will commence shortly and the company confirms it will update the market in due course
  • Shares in the company are down 33.3 per cent, trading at 0.2 cents as of 1:51 pm AEST
Previous article
Rohlik Group: Raises €220M in Series D Funding
Next article
TNG: Appoints Clough as Lead Engineer for Mount Peake
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Regulators Strengthen Global Crackdown on Finfluencers

A new collaborative approach targets financial influencers amid rising concerns.Highlights: Financial regulators unite to control finfluencers' market impact.Concerns...
FinTech

ECB Strengthens Digital Euro Rollout with Standard Setter Agreements

New collaborations aim to facilitate the digital euro's global integration.Highlights: ECB partners with key global standard setters.Agreements aim...
FinTech

CreditNature Strengthens Nature Restoration Funding Through Everyday Transactions

New partnership enables businesses to support environmental initiatives seamlessly.Highlights: CreditNature teams up with Stabiliti for eco-friendly funding.Businesses can...
FinTech

FedNow Strengthens Instant Payments Security with New API Tool

New API tool enhances security for immediate digital transactions in the U.S.Highlights: FedNow introduces a new API tool...